Table 2.
Study group | Study design | Detection method | Phenotype EMP | Main findings |
---|---|---|---|---|
Joop et al. [23] | Case-control MODS and sepsis (n = 9) |
Flow cytometry isolated MP frozen samples |
CD62E+/ Annexin V+ CD144+/ Annexin V+ |
(i) Lower number CD62E+ EMP (ii) Unchanged number CD144+ EMP |
| ||||
Mortaza et al. [24] | Rat cecal ligation and puncture model | Flow cytometry PFP |
CD54+/ Annexin V+ |
(i) Unchanged EMP in sepsis (ii) Septic MP caused vasoplegic shock in healthy rats |
| ||||
Mostefai et al. [25] | Case-control sepsis (n = 36) mouse model: injection of septic MP |
Flow cytometry PFP frozen samples |
CD146+ | (i) Increased EMP in sepsis (ii) Septic MP induced increased responsiveness to vasoconstrictors in aortic rings |
| ||||
Nieuwland et al. [26] | Case-control meningococcal sepsis (n = 7) |
Flow cytometry isolated MP |
CD62E+/ Annexin V+ |
Nonsignificant increase in sepsis |
| ||||
Ogura et al. [27] | Case-control severe SIRS (n = 28, sepsis = 12) |
Flow cytometry PRP |
CD54+ CD31+ | EMP increased in sepsis |
| ||||
Pérez-Casal et al. [28] | Case control study of APC treated sepsis patients | Flow cytometry isolated MP |
CD13+ EPCR+ | Increased CD13+ EPCR+ MP |
| ||||
Soriano et al. [29] | Case control severe sepsis (n = 35) |
Flow cytometry PPP |
CD31+ CD42b− | (i) EMP higher in severe sepsis (ii) EMP higher in survivors (iii) Negative correlation with SOFA on D2 and D3 |
| ||||
van Ierssel et al. [22] | Case-control severe sepsis (n = 26) |
Flow cytometry PPP |
CD31+ CD42b− | Unchanged number of EMP versus healthy controls |
EMP: endothelial microparticles; MODS: multiorgan dysfunction syndrome; MP: microparticle; PFP: platelet free plasma; PPP: platelet poor plasma; PRP: platelet rich plasma; SOFA: sequential organ dysfunction assessment.